Drug Spending To Rebound Due to Emerging Market Growth
This article was originally published in PharmAsia News
Pharmerging markets will double their spending on pharmaceuticals over the next five years as populations grow and more consumers get access to healthcare through government programs, said a recent IMS report on global medicines spending.
You may also be interested in...
Two companies in the biopharma space began trading publicly this week, one to pay off debt, the other to fund an early-stage pipeline.
The biotech is shifting gears after clinical hold on its lead drug was unlikely to be lifted, but the early-stage candidate that it's placing its hopes on is raising red flags for analysts and investors.
The biotech confirmed that a recent death during a clinical trial was not caused by its early-stage gene therapy.